antithrombotic peptides (Emory University)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameantithrombotic peptides (Emory University)
Drug Alias Nameantithrombotic thrombin variants (Emory University)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCoagulation factor inhibitors
TargetsCoagulation factor
Therapy Area/IndicationsVascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEmory University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEmory University
Active IndicationsN/A
Inactive IndicationsVascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A